Trials / Completed
CompletedNCT05893667
Evaluation of Inflammatory Markers in LARC Patients
Evaluation of Pretreatment Inflammatory Markers in Predicting Response to nCRT and Prognosis in LARC Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 245 (actual)
- Sponsor
- Hospital Pedro Hispano · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Introduction: In locally advanced rectal cancers (LARC), TNM staging is far from optimal. We aimed to investigate the value of previously described circulating biomarkers as predictors of prognosis. Methods: Retrospective analysis of 245 LARC patients diagnosed between January 2010 and December 2022, who underwent neoadjuvant chemoradiotherapy and surgery at two centers. A Cox regression and Kaplan-Meier analysis were performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Inflammatory markers | analysis of inflammatory scores |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2022-12-01
- Completion
- 2023-05-01
- First posted
- 2023-06-08
- Last updated
- 2023-06-12
Source: ClinicalTrials.gov record NCT05893667. Inclusion in this directory is not an endorsement.